雜志介紹

Antiviral Research雜志介紹

《Antiviral Research》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱抗病毒研究，本刊主要出版、報道醫(yī)學(xué)-PHARMACOLOGY & PHARMACY領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為4.5，最新CiteScore 指數(shù)為17.1。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Ciliatoside A, isolated from Peristrophe japonica, inhibits HBsAg expression and cccDNA transcription by inducing autophagy

  Author: Fang, Ren; Ming, Tan; Ng, Jerome P. L.; Guo, Wu An; Yu, Yuan Si; Hui, Zhang; Hua, Ren Ji; Tao, Cheng Sheng; Juan, Zhang; Hong, Lo Hang; Wong, Vincent Kam Wai; Law, Betty Yuen Kwan; Juan, Chen

• Multiplication of defective Ebola virus in a complementary permissive cell line

  Author: Tong, Xian-Kun; Li, Heng; Yang, Li; Xie, Shi-Zhe; Xie, Sha; Gong, Ying; Peng, Cheng; Gao, Xiao-Xiao; Shi, Zheng-Li; Yang, Xing-Lou; Zuo, Jian-Ping

• Intranasal delivery of replicating mRNA encoding hACE2-targeting antibody against SARS-CoV-2 Omicron infection in the hamster

  Author: Zhang, Ya-Nan; Zhang, Hong-Qing; Wang, Gui-Feng; Zhang, Zhe-Rui; Li, Jia-Qi; Chen, Xiao-Ling; Hu, Yan-Yan; Zeng, Xiang-Yue; Shi, Yu-Jia; Wang, Jing; Li, Ying-Hua; Li, Xiao-Dan; Wang, Chun-He; Zhu, Bing; Zhang, Bo

• PI3K/AKT-mediated autophagy inhibition facilitates mast cell activation to enhance severe inflammatory lung injury in influenza A virus- and secondary Staphylococcus aureus-infected mice

  Author: Tang, Yuling; Su, Ruijing; Gu, Qingyue; Hu, Yanxin; Yang, Hanchun

英文介紹

Antiviral Research雜志英文介紹

Antiviral Research publishes research reports, short communications, review articles and commentaries on the control of viral infections in humans and animals. Its scope encompasses: antiviral drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action; new or improved vaccines against viral infections of humans; assessments of drug and vaccine safety; evolution of drug- or vaccine-resistant viruses and the development of effective countermeasures; identification and validation of new drug targets; laboratory animal models of viral diseases; pathogenesis of viral diseases and mechanisms of viral evasion of host immune responses.